MedTrace Logo

Assessment of Compliance With Antihypertensive Telmisartan Therapy

NCT00470886 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3400

Last updated 2012-11-16

No results posted yet for this study

Summary

The purpose of this study is to asses the efficacy and safety of Telmisartan depending on the use of an electronic therapy monitoring device (HelpingHand) in a real life setting and to asses patients compliance to the therapy with Telmisartan in relation to use of electronic therapy monitoring device.

Conditions

Interventions

DRUG

Telmisartan (Kinzal/Pritor, BAY68-9291)

Primary care clinic hypertensive patients for whom physician decided to start the treatment with telmisartan

Sponsors & Collaborators

  • Bang & Olufsen Medicom

    collaborator INDUSTRY

  • Bayer

    lead INDUSTRY

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2010-01-31
Completion
2010-01-31

Countries

  • Poland
  • Slovakia

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00470886 on ClinicalTrials.gov